PRP
4 min readDermaheal HL Scalp Mesotherapy for Early Thinning
Educational reading for licensed practitioners — not clinical or injection guidance.
For patients noticing the first signs of thinning — more scalp showing at the part, a smaller ponytail, hair that feels less dense than it did — the natural question is what to do before the loss becomes advanced. Scalp mesotherapy with a ready-made cocktail such as Dermaheal HL is one of the interventions positioned for exactly this early window, and its appeal is convenience: an off-the-shelf, standardised product delivered as a course of micro-injections.
What Dermaheal HL Is
Dermaheal HL is a pre-formulated mesotherapy solution designed for the scalp, combining biomimetic peptides with a blend of vitamins, amino acids and other ingredients intended to support the follicular environment. The "HL" denotes its anti-hair-loss positioning. Unlike autologous platelet therapy (PRP), which is prepared chairside from the patient's own blood, Dermaheal HL is a ready-made product — there is no blood draw or centrifugation, which is part of its practical attraction for both clinician and patient.
The concept is mesotherapy in the classic sense: deliver active ingredients directly into the scalp, close to the follicles, in small, repeated doses rather than relying on topical absorption through the skin surface.
Why "Early" Matters
Mesotherapy of this kind is best framed as support for a follicle that is miniaturising, not resurrection of one that is gone. In early-stage thinning there are still active, if weakening, follicles to work with, and improving their environment has the most to offer at that point. Once an area has progressed to smooth, long-established baldness, the follicles that would respond are largely absent, and expectations should drop accordingly. Choosing patients in the earlier phases is the single biggest factor in whether scalp mesotherapy looks worthwhile.
How a Course Is Delivered
Treatment is given as a series of superficial intradermal micro-injections spread across the thinning zones of the scalp, using a fine needle or a mesotherapy gun. It is typically delivered as a course — commonly several sessions over the initial weeks — followed by maintenance sessions to sustain any benefit. As with any scalp injection, transient tenderness, small bumps at injection points, redness or minor bruising are commonly reported and usually settle quickly.
Because it is off-the-shelf, Dermaheal HL is straightforward to slot into a wider protocol; some clinics rotate or combine it with other in-clinic hair options such as polynucleotide presentations like Plinest Hair, peptide-based products such as the Dr. CYJ Hair Filler, or a general mesotherapy hair blend like the Mesomedica hair cocktail. Because there is no blood draw, it is also easy to alternate with autologous platelet therapy across a plan for patients who want both a standardised product and their own growth factors.
Where It Fits — and Its Limits
Scalp mesotherapy is a supportive, maintenance treatment, not a cure. The evidence base for ready-made cocktails is more modest than for the mainstays of pattern hair loss, and results are individually variable. That is why it works best as one layer of a combination approach rather than a standalone answer: for androgenetic loss, the evidence-led foundation remains medical therapy — topical or low-dose oral minoxidil, and finasteride where appropriate — with in-clinic procedures added on top. Minoxidil and finasteride are the FDA-approved treatments for pattern loss; Dermaheal HL is a CE-marked mesotherapy product used internationally and is not FDA-approved for hair loss.
A few practical points:
- Diagnose first. Confirm the type of hair loss; mesotherapy suits some causes and not others.
- Set expectations early. Best used at the first signs of thinning, as support rather than regrowth of long-lost hair.
- Commit to the course and maintenance. Benefits fade if treatment lapses.
- Screen as for any injectable. Active scalp infection or inflammation, bleeding disorders, pregnancy and lactation, and relevant allergy history are standard exclusions.
The Takeaway
Dermaheal HL is a convenient, standardised scalp mesotherapy option aimed squarely at early thinning, delivered as a course of micro-injections without the blood draw of PRP. It is genuinely useful as part of a broader, medically-informed plan and for the right patient caught early — but it is a supportive maintenance treatment with modest, variable results, not a cure or a replacement for proven medical therapy.
Explore scalp options in the hair growth range.